Beyond Imagination and GelSight Announce Pilot to Pair State-of-the-art Tactile Sensing With Cutting-edge Telepresence Robotics

Beyond Imagination and GelSight have initiated a pilot to study the feasibility of using Beyond Imagination’s humanoid robotic technology to remotely operate GelSight’s tactile sensors.

NUBURU Secures Fresh Funding and Appoints COO and VP of Global Sales to Accelerate Expansion

Additional growth capital brings NUBURU’s valuation to approximately $350M and executive appointments will accelerate commercialization of its blue laser technology

InterVenn Promotes Klaus Lindpaintner to InterVenn Distinguished Scientist; Appoints Tillman Pearce as Chief Medical Officer

Klaus has served so far as the company’s Chief Medical and Scientific Officer and will now focus on serving as InterVenn’s scientific alliance ambassador to the global glycobiology constituency.

NTx Appoints Former Chairman and CEO of Allstate Corporation Edward Liddy to Board of Directors

Mr. Liddy brings over 30 years of executive leadership, IPO and private equity experience, and board involvement with Abbott Laboratories, AbbVie, and Boeing to help guide NTx’s commercialization efforts

Albemarle and 6K Sign Joint Development Agreement to Develop Novel Lithium Battery Materials

Albemarle to invest in 6K and sponsor development of UniMelt® system for advanced, sustainable materials production

6K Appoints Former Allstate CEO and Chairman Edward Liddy to its Board of Directors

This appointment brings peerless experience as a previous board member of Boeing, 3M, Abbott and Goldman Sachs to support 6K’s accelerated growth

Battery Leaders Voltaiq, Batemo and Energy Assurance Release First Independent Battery Index

First independent Battery Index provides the ‘missing link’ for manufacturers of battery-powered products from consumer electronics to EVs

Battery Analytics Leader Voltaiq Names Tech Executive Martin Thall President and COO

Thall brings 30+ years of computer technology experience with Microsoft, Verizon and Visteon

InterVenn Biosciences Names Brian Hogan as Chief Financial Officer

Life sciences industry veteran brings decades of experience in public and private companies to scale the company’s capabilities and operations for accelerated growth

InterVenn Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022

InterVenn Biosciences is scheduled to present at the J.P. Morgan 40th Annual Healthcare Conference on January 12, 2022.